Cosmos Health Inc. (NASDAQ:COSM) Short Interest Update

Cosmos Health Inc. (NASDAQ:COSM) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 189,700 shares, a decrease of 53.3% from the February 29th total of 406,200 shares. Currently, 1.3% of the shares of the company are short sold. Based on an average trading volume of 306,100 shares, the days-to-cover ratio is presently 0.6 days.

Insider Buying and Selling

In other Cosmos Health news, CEO Grigorios Siokas purchased 60,000 shares of the company’s stock in a transaction on Friday, February 16th. The stock was acquired at an average cost of $0.83 per share, for a total transaction of $49,800.00. Following the purchase, the chief executive officer now directly owns 1,394,597 shares of the company’s stock, valued at approximately $1,157,515.51. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 18.74% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Armistice Capital LLC bought a new position in shares of Cosmos Health during the 4th quarter valued at approximately $1,882,000. Vanguard Group Inc. bought a new position in shares of Cosmos Health during the 3rd quarter valued at approximately $212,000. BlackRock Inc. boosted its position in shares of Cosmos Health by 9.0% during the 2nd quarter. BlackRock Inc. now owns 291,914 shares of the company’s stock valued at $873,000 after acquiring an additional 24,117 shares during the last quarter. State Street Corp bought a new position in shares of Cosmos Health during the 1st quarter valued at approximately $76,000. Finally, Geode Capital Management LLC bought a new stake in Cosmos Health in the first quarter worth $327,000. 12.61% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Taglich Brothers restated a “speculative buy” rating on shares of Cosmos Health in a research note on Tuesday, February 20th.

Cosmos Health Stock Performance

COSM stock remained flat at $0.71 during midday trading on Thursday. The company’s stock had a trading volume of 175,417 shares, compared to its average volume of 301,587. Cosmos Health has a 1-year low of $0.61 and a 1-year high of $4.05. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.06 and a quick ratio of 1.79. The business has a 50 day moving average price of $0.84 and a 200 day moving average price of $1.09.

Cosmos Health Company Profile

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.